UniProt | Protein Name |
---|---|
Q9H553 |
|
GO Term | Evidence Code | PMID |
---|---|---|
protein N-linked glycosylation | ||
dolichol-linked oligosaccharide biosynthetic process | ||
protein glycosylation | ||
oligosaccharide-lipid intermediate biosynthetic process | ||
response to calcium ion |
|
GO Term | Evidence Code | PMID |
---|---|---|
nucleus |
|
|
cytoplasm |
|
|
endoplasmic reticulum membrane | ||
cytoplasmic side of endoplasmic reticulum membrane | ||
membrane |
GO Term | Evidence Code | PMID |
---|---|---|
alpha-1,3-mannosyltransferase activity | ||
GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity | ||
calcium-dependent protein binding |
|
|
protein binding | ||
GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
Species | Protein | mRNA |
---|---|---|
Arabidopsis thaliana | NP_178001 | NM_106527 |
Saccharomyces cerevisiae | CAA96768 | Z72587 |
Rattus norvegicus | XP_232987 | XM_232987 |
Drosophila melanogaster | NP_647772 | NM_139515 |
Caenorhabditis elegans | NP_495010 | NM_062609 |
Mus musculus | NP_064382 | NM_019998 |
HPO ID | HPO Term |
---|---|
HP:0000007 | Autosomal recessive inheritance |
HP:0000218 | High palate |
HP:0000252 | Microcephaly |
HP:0000286 | Epicanthus |
HP:0000369 | Low-set ears |
HP:0000407 | Sensorineural hearing impairment |
HP:0000431 | Wide nasal bridge |
HP:0000494 | Downslanted palpebral fissures |
HP:0000505 | Visual impairment |
HP:0000508 | Ptosis |
Disease ID | Disease Name |
---|---|
OMIM:616228 |
|
ORPHA:353327 |
|
OMIM:607906 |
|
ORPHA:79326 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
103253383 | CARSF14039 | ||
115604824 | STRHB14861 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024